- Home
- NNDM vs ITOS Comparison
NNDM vs ITOS Comparison
Compare NNDM & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNDM
- ITOS
- Stock Information
- Founded
- NNDM 2012
- ITOS 2011
- Country
- NNDM Israel
- ITOS United States
- Employees
- NNDM N/A
- ITOS N/A
- Industry
- NNDM Electrical Products
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NNDM Technology
- ITOS Health Care
- Exchange
- NNDM Nasdaq
- ITOS Nasdaq
- Market Cap
- NNDM 322.3M
- ITOS 270.7M
- IPO Year
- NNDM N/A
- ITOS 2020
- Fundamental
- Price
- NNDM $1.63
- ITOS $6.67
- Analyst Decision
- NNDM
- ITOS Strong Buy
- Analyst Count
- NNDM 0
- ITOS 3
- Target Price
- NNDM N/A
- ITOS $25.67
- AVG Volume (30 Days)
- NNDM 1.6M
- ITOS 550.0K
- Earning Date
- NNDM 06-02-2025
- ITOS 04-28-2025
- Dividend Yield
- NNDM N/A
- ITOS N/A
- EPS Growth
- NNDM N/A
- ITOS N/A
- EPS
- NNDM N/A
- ITOS N/A
- Revenue
- NNDM $57,775,000.00
- ITOS $35,000,000.00
- Revenue This Year
- NNDM N/A
- ITOS N/A
- Revenue Next Year
- NNDM N/A
- ITOS $31.74
- P/E Ratio
- NNDM N/A
- ITOS N/A
- Revenue Growth
- NNDM 2.59
- ITOS 177.89
- 52 Week Low
- NNDM $1.34
- ITOS $4.80
- 52 Week High
- NNDM $2.75
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- NNDM 50.31
- ITOS 49.00
- Support Level
- NNDM $1.57
- ITOS $6.18
- Resistance Level
- NNDM $1.71
- ITOS $7.80
- Average True Range (ATR)
- NNDM 0.07
- ITOS 0.50
- MACD
- NNDM 0.03
- ITOS -0.05
- Stochastic Oscillator
- NNDM 71.43
- ITOS 29.94
About NNDM Nano Dimension Ltd.
Nano Dimension Ltd is a provider of intelligent machines for the fabrication of Additively Manufactured Electronics (AME). High-fidelity active electronic and electromechanical subassemblies are integral enablers of autonomous intelligent drones, cars, satellites, smartphones, and in medical devices. The portfolio of the company includes Mechanical, Chemical, Applications, Industrial Design, and Artificial Learning areas. Nano Dimension machines serve cross-industry needs by depositing proprietary consumable conductive and dielectric materials simultaneously, while concurrently integrating in-situ capacitors, antennas, coils, transformers, and electromechanical components, to function at an unprecedented performance.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.